Percutaneous Ventricular Assist Device
UnitedHealthcare Medicare Advantage medical policy governing when percutaneous insertion of an endovascular cardiac assist device (pVAD) is considered reasonable and necessary, associated applicable procedure/diagnosis codes, references to CMS LCDs/LCAs, clinical evidence, and FDA/ guideline context. Applies where no conflicting LCD/NCD exists; compliance with LCDs/LCAs required when present.
Policy reformatted and reorganized to a new template; changed classification from 'Policy Guideline' to 'Medical Policy' and added Clinical Evidence, FDA, and References sections.
Updated CMS-related documents list and MAC/state jurisdictions; added Virginia jurisdiction notation.
Removed CPT codes 33992, 33993, and 33997 and ICD procedure code 5A02216 from Applicable Codes.
Replaced 'covered' wording with 'considered reasonable and necessary' in coverage rationale language.
Added reference link to the Medicare Advantage Medical Policy titled Cardiovascular Diagnostic and Therapeutic Procedures and removed reference link to an older Coverage Summary.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.